Characterization and modeling of gain spectra of single-layer InAs/InP(100) quantum dot amplifiers

In this contribution we present the small signal net modal gain measurement results of single-layer InAs/InP(100) quantum dot amplifiers in 1.6 to 1.8 µm wavelength range. The material shows sufficient optical gain to be used in the long-wavelength optical coherence tomography. The modal gain has been observed as a function of current density and temperature. An improved rate equation model has been applied to analyse the measurements. A good fit of the theory to the measurements was obtained with a temperature dependent carrier injection efficiency which is below 2%

Size dependent exciton g-factor in self-assembled InAs/InP quantum dots

We have studied the size dependence of the exciton g-factor in self-assembled InAs/InP quantum dots. Photoluminescence measurements on a large ensemble of these dots indicate a multimodal height distribution. Cross-sectional Scanning Tunneling Microscopy measurements have been performed and support the interpretation of the macro photoluminescence spectra. More than 160 individual quantum dots have systematically been investigated by analyzing single dot magneto-luminescence between 1200nm and 1600 nm. We demonstrate a strong dependence of the exciton g-factor on the height and diameter of the quantum dots, which eventually gives rise to a sign change of the g-factor. The observed correlation between exciton g-factor and the size of the dots is in good agreement with calculations. Moreover, we find a size dependent anisotropy splitting of the exciton emission in zero magnetic field.Comment: 15 pages, 7 figure

Measurement and analysis of temperature-dependent optical modal gain in single-layer InAs/InP(100) quantum-dot amplifiers in the 1.6- to 1.8-µm wavelength range

In this paper, measurements and analysis of the small-signal net modal gain of single-layer InAs/InP(100) quantum-dot (QD) optical amplifiers are presented. The amplifiers use only a single layer of InAs QDs on top of a thin InAs quantum well. The devices have been fabricated using a layer stack that is compatible with active–passive integration scheme, which makes further integration possible. The measurement results show sufficient optical gain in the amplifiers and can thus be used in applications such as lasers for long-wavelength optical coherence tomography and gas detection. The temperature dependence of the modal gain is also characterized. An existing rate-equation model was adapted and has been applied to analyze the measured gain spectra. The current injection efficiency has been introduced in the model to obtain a good fit with the measurement. It is found that only a small portion ($sim$1.7%) of the injected carriers is actually captured by the QDs. The temperature dependence of several parameters describing the QDs is also discovered. The mechanisms causing the blue shift of peak gain as the current density increases and the temperature changes are analyzed and discussed in detail

Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists

We expanded on a series of pyrido[2,1-f]purine-2,4-clione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [S-35]GTP gamma S binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)-k(off)-K-D kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds' binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery

Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists

We expanded on a series of pyrido[2,1-f]purine-2,4-clione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [S-35]GTP gamma S binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)-k(off)-K-D kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds' binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery

Stark deceleration of CaF molecules in strong- and weak-field seeking states

We report the Stark deceleration of CaF molecules in the strong-field seeking ground state and in a weak-field seeking component of a rotationally-excited state. We use two types of decelerator, a conventional Stark decelerator for the weak-field seekers, and an alternating gradient decelerator for the strong-field seekers, and we compare their relative merits. We also consider the application of laser cooling to increase the phase-space density of decelerated molecules.Comment: 10 pages, 8 figure

Measuring ‘Need for Recovery’ as an indicator of staff well-being in the emergency department: a survey study

No embargo required.BackgroundThe Need for Recovery (NFR) Scale is an 11-item questionnaire that assesses how work affects intershift recovery. Items are summated to form a score with a maximum value of 100. Previously reported scores range from 38 in nurses to 55 in miners. This study aimed to determine the NFR Score among ED staff and to identify whether the NFR Score was associated with characteristics potentially implicated with recovery from work.MethodsStaff in a single ED in the South West of England (annual attendances of 93 000) were asked to complete an electronic questionnaire incorporating the NFR Scale plus additional items relating to demographic, work-related and well-being characteristics, in their own time during January 2018. Descriptive statistics are presented, including median NFR Scores and associations with additional characteristics. Thematic analysis of free-text comments from an open-ended question was undertaken.ResultsOne hundred and sixty-eight responses were obtained (80.3% capture). Median NFR Score across all staff groups was 81.8 out of 100.0 (95% CI 72.7 to 81.8). Shift duration exceeding 12 hours, dissatisfaction with work–life balance and self-reported perceptions of burnout were associated with significantly elevated NFR Scores. Themes resulting from the open-ended question were ‘barriers to intershift recovery’ and ‘coping with work’.ConclusionThe NFR Scores in this study exceeded scores reported elsewhere and were associated with some demographic, occupational and well-being characteristics. The NFR Scale has utility to measure the need for intershift recovery among ED staff. A larger study is warranted to identify specific determinants of recovery and to provide recommendations.</jats:sec

Lipid homeostasis and inflammatory activation are disturbed in classically activated macrophages with peroxisomal β-oxidation deficiency

Macrophage activation is characterized by pronounced metabolic adaptation. Classically activated macrophages show decreased rates of mitochondrial fatty acid oxidation and oxidative phosphorylation and acquire a glycolytic state together with their pro-inflammatory phenotype. In contrast, alternatively activated macrophages require oxidative phosphorylation and mitochondrial fatty acid oxidation for their anti-inflammatoryfunction. Although it is evident that mitochondrial metabolism is regulated during macrophage polarization and essential for macrophagefunction, little is known on the regulation and role of peroxisomal -oxidation during macrophage activation. In this study, we show that peroxisomal -oxidation is strongly decreased in classically activated bone-marrow-derived macrophages (BMDM) and mildly induced in alternatively activated BMDM. To examine the role of peroxisomal -oxidation in macrophages, we used Mfp2(-/-) BMDM lacking the key enzyme of this pathway. Impairment of peroxisomal -oxidation in Mfp2(-/-) BMDM did not cause lipid accumulation but rather an altered distribution of lipid species with very-long-chain fatty acids accumulating in the triglyceride and phospholipid fraction. These lipid alterations in Mfp2(-/-) macrophages led to decreased inflammatory activation of Mfp2(-/-) BMDM and peritoneal macrophages evidenced by impaired production of several inflammatory cytokines and chemokines, but did not affect anti-inflammatory polarization. The disturbed inflammatory responses of Mfp2(-/-) macrophages did not affect immune cell infiltration, as mice with selective elimination of MFP2 from myeloid cells showed normal monocyte and neutrophil influx upon challenge with zymosan. Together, these data demonstrate that peroxisomal -oxidation is involved in fine-tuning the phenotype of macrophages, probably by influencing the dynamic lipid profile during macrophage polarization